<DOC>
	<DOC>NCT02095431</DOC>
	<brief_summary>Acute kidney injury (AKI), is a common complication of patients undergoing liver transplantation. Timing and definition of AKI, usually based on serum creatinine, have been inaccurate and inconsistent. We hypothesized that the pattern of novel biomakers elevation could be a prognostic tool to provide information on the risk of progression of AKI, the need for RRT and mortality.</brief_summary>
	<brief_title>Acute Kidney Injury Biomarkers: Diagnosis and Application in Pre-operative Period of Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>Older than 18 years Reception liver transplantation CKD stage 4 / 5 Combined organ transplants Patients receiving dialysis before liver transplant operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>patients undergoing the liver transplantation</keyword>
	<keyword>acute kidney injury</keyword>
</DOC>